Research & Publications
Terri Parker, MD, is an Assistant Professor of Medicine at the Yale School of Medicine in the section of Hematology. Dr. Parker completed her internal medicine residency at the University of Connecticut followed by a fellowship program in hospice and palliative medicine. She also completed a fellowship in hematology and medical oncology at Yale University School of Medicine.
Dr. Parker serves as the assistant medical director at Smilow Cancer Hospital in North Haven. She is a member of the protocol review committee (PRC) at Yale Cancer Center, which is charged with the scientific evaluation of all cancer clinical protocols and amendments proposed at Yale prior to initiation. Dr. Parker currently serves as co-chair of the Multiple Myeloma Committee for ClinicalPath, which presents evidence-based oncology pathways to academic and community practices.
Dr. Parker treats patients with plasma cell dyscrasias, including multiple myeloma and related diseases such as AL amyloidosis, monoclonal gammopathy of undetermined significance (MGUS), plasma cell leukemia, smoldering multiple myeloma, and Waldenstrom’s macroglobulinemia. She has experience with clinical trials focused on novel therapies and drug combinations with a goal of advancing the standard of care for patients with AL amyloidosis, newly diagnosed and relapsed refractory multiple myeloma.
Education & Training
- FellowshipYale University School of Medicine (2012)
- FellowshipUniversity of Connecticut Health Center (2009)
- ResidencyUniversity of Connecticut Health Center (2008)
- MDSt. George's University School of Medicine Grenada (2005)
- BSUniversity of Pittsburgh (2001)
Honors & Recognition
|David S. Fischer Teaching Award for Outstanding Faculty Teaching and Mentoring of Fellows in Medical Oncology
|Letter of Recognition from Evaluation and Promotions Committee
|University of Connecticut
|American Society of Hematology
|Chosen as an inaugural American Society of Hematology (ASH) Ambassador. This was a formal volunteer role to support recruitment and retention of trainees to hematology and to ASH through promotion of ASH’s career development and training programs.
|2018 - 2021
|Faculty Advisory Council, Yale University School of Medicine
|The purpose of the Faculty Advisor Council is to provide a forum for a diverse group of representatives to bring new ideas and concerns from a broad range of faculty to the Dean’s office. I served a two year term representing the sections of hematology/medical oncology.
|2015 - 2017
|Protocol Review Committee, Yale Cancer Center, Yale University School of Medicine
|Member of the scientific protocol review committee for the cancer center. The committee is responsible for reviewing the scientific merit, priorities, and progress of Yale Cancer Center clinical research trials.
|2015 - Present